Cédric Tremblay
@cedricstremblay.bsky.social
research group leader - hematopoiesis & leukemia | faculty UofM | adjunct MonashU | advocate - belonging, equity, diversity & inclusion | 🇨🇦🇦🇺🏳️🌈
November 3, 2025 at 1:51 AM
Reposted by Cédric Tremblay
Congratulations to PROMISE PI Dr. Cédric Tremblay on receiving a @researchmb.bsky.social NIOG Grant for his project, “Investigating the Role of Interferon Signaling in T-cell Acute Lymphoblastic Leukemia.” #CHRIM #CCMB #CancerResearch
researchmanitoba.ca/niog-2025/
researchmanitoba.ca/niog-2025/
Research Manitoba Announces $1.8M in Funding for 24 New Investigators - Research Manitoba
researchmanitoba.ca
October 28, 2025 at 5:49 PM
Congratulations to PROMISE PI Dr. Cédric Tremblay on receiving a @researchmb.bsky.social NIOG Grant for his project, “Investigating the Role of Interferon Signaling in T-cell Acute Lymphoblastic Leukemia.” #CHRIM #CCMB #CancerResearch
researchmanitoba.ca/niog-2025/
researchmanitoba.ca/niog-2025/
17 ans de carrière postdoctorale!
17 years of postdoctoral career!
17 years of postdoctoral career!
June 8, 2025 at 11:25 PM
17 ans de carrière postdoctorale!
17 years of postdoctoral career!
17 years of postdoctoral career!
Reposted by Cédric Tremblay
Congratulations to Mathew and Jonathon from @cedricstremblay.bsky.social lab, Great Work!!
#PediatricLeukemia #CancerResearch #CCMB #CHRIM
#PediatricLeukemia #CancerResearch #CCMB #CHRIM
May 21, 2025 at 7:15 PM
Congratulations to Mathew and Jonathon from @cedricstremblay.bsky.social lab, Great Work!!
#PediatricLeukemia #CancerResearch #CCMB #CHRIM
#PediatricLeukemia #CancerResearch #CCMB #CHRIM
That’s us! So proud!
Thanks @isehsociety.bsky.social for this opportunity to speak about our team
Thanks @isehsociety.bsky.social for this opportunity to speak about our team
This month on #SimplyBlood🩸we're featuring the Tremblay Lab @cedricstremblay.bsky.social based out of the University of Manitoba, Canada. Read about their latest projects and accomplishments on www.simplyblood.org
May 8, 2025 at 11:50 AM
That’s us! So proud!
Thanks @isehsociety.bsky.social for this opportunity to speak about our team
Thanks @isehsociety.bsky.social for this opportunity to speak about our team
April 21, 2025 at 2:58 PM
Reposted by Cédric Tremblay
Explore the latest findings in this month's #ExpHem issue, featuring articles by @milsommick.bsky.social @smckinneyfreeman.bsky.social and more! www.exphem.org
March 26, 2025 at 4:30 PM
Explore the latest findings in this month's #ExpHem issue, featuring articles by @milsommick.bsky.social @smckinneyfreeman.bsky.social and more! www.exphem.org
First single-cell multi-omics samples generated in the lab!
Great team effort!
Great team effort!
March 26, 2025 at 10:14 PM
First single-cell multi-omics samples generated in the lab!
Great team effort!
Great team effort!
Reposted by Cédric Tremblay
This is just insane. Making America healthy again also means making sure kids are up to date with vaccination.
This goes against their own slogan.
This is a push of a dangerous agenda
www.politico.com/news/2025/01...
This goes against their own slogan.
This is a push of a dangerous agenda
www.politico.com/news/2025/01...
RFK Jr.’s allies have a plan to upend childhood vaccination
Robert F. Kennedy’s Jr. advisers are sparring over how far he should go on vaccines as health secretary.
www.politico.com
January 25, 2025 at 5:54 AM
This is just insane. Making America healthy again also means making sure kids are up to date with vaccination.
This goes against their own slogan.
This is a push of a dangerous agenda
www.politico.com/news/2025/01...
This goes against their own slogan.
This is a push of a dangerous agenda
www.politico.com/news/2025/01...
Reposted by Cédric Tremblay
Here, Ken Omollo is presenting the data from a clinical trial run by Dr Keith Fowke
Where we used aspirin to determine if it can decrease HIV target cells at the genital tract to help preventing HIv infection in high risk women.
Our pilot study had shown 33% ⬇️ in general pop.
Where we used aspirin to determine if it can decrease HIV target cells at the genital tract to help preventing HIv infection in high risk women.
Our pilot study had shown 33% ⬇️ in general pop.
January 29, 2025 at 8:33 AM
Here, Ken Omollo is presenting the data from a clinical trial run by Dr Keith Fowke
Where we used aspirin to determine if it can decrease HIV target cells at the genital tract to help preventing HIv infection in high risk women.
Our pilot study had shown 33% ⬇️ in general pop.
Where we used aspirin to determine if it can decrease HIV target cells at the genital tract to help preventing HIv infection in high risk women.
Our pilot study had shown 33% ⬇️ in general pop.
Reposted by Cédric Tremblay
Thanks to CBC MB with Marcy Markusa for giving me the opportunity to talk about the impact that the freeze for PEPFAR and the end of USAID has on UM researchers and the service we offer in Nairobi, Kenya, to key populations.
www.cbc.ca/listen/live-...
www.cbc.ca/listen/live-...
© CBC/Radio-Canada 2025. All rights reserved.
www.cbc.ca
February 6, 2025 at 5:33 PM
Thanks to CBC MB with Marcy Markusa for giving me the opportunity to talk about the impact that the freeze for PEPFAR and the end of USAID has on UM researchers and the service we offer in Nairobi, Kenya, to key populations.
www.cbc.ca/listen/live-...
www.cbc.ca/listen/live-...
Reposted by Cédric Tremblay
TODAY! Don't miss @cedricstremblay.bsky.social speaking at NOON CST
FRIDAY FEB 14 at NOON CST in A207 Chown Cedric Tremblay @cedricstremblay.bsky.social will be speaking about "Investigating the mechanisms of #chemotherapy resistance in T-cell lymphoblastic leukemia" @um-radyfhs.bsky.social and via ZOOM: 671 0881 4891 PW:346193
February 14, 2025 at 4:21 PM
TODAY! Don't miss @cedricstremblay.bsky.social speaking at NOON CST
Reposted by Cédric Tremblay
ROMISE PI Dr. Cedric Tremblay @cedricstremblay.bsky.social will be presenting on "Investigating the Mechanisms of Chemotherapy Resistance in T-Cell Lymphoblastic Leukemia" on Friday, February 14, at noon CST in A207 Chown. #PediatricLeukemia #CancerResearch #CCMB #CHRIM
February 11, 2025 at 8:20 PM
ROMISE PI Dr. Cedric Tremblay @cedricstremblay.bsky.social will be presenting on "Investigating the Mechanisms of Chemotherapy Resistance in T-Cell Lymphoblastic Leukemia" on Friday, February 14, at noon CST in A207 Chown. #PediatricLeukemia #CancerResearch #CCMB #CHRIM
Reposted by Cédric Tremblay
“We are the proud home of nation-leading universities and research institutions that save lives, create jobs, and help secure a better future.”
Mass. AG, Andrea Campbell
#MedSky #research #science #NIH
www.bostonglobe.com/2025/02/10/m...
Mass. AG, Andrea Campbell
#MedSky #research #science #NIH
www.bostonglobe.com/2025/02/10/m...
‘You are a president, not a king.’ Mass. and 21 other states sue Trump administration over NIH research funding cuts - The Boston Globe
The lawsuit, filed Monday in US District Court for Massachusetts, was co-led by Andrea Campbell and asserts that the Trump administration’s changes violate the Administrative Procedure Act.
www.bostonglobe.com
February 10, 2025 at 11:13 PM
“We are the proud home of nation-leading universities and research institutions that save lives, create jobs, and help secure a better future.”
Mass. AG, Andrea Campbell
#MedSky #research #science #NIH
www.bostonglobe.com/2025/02/10/m...
Mass. AG, Andrea Campbell
#MedSky #research #science #NIH
www.bostonglobe.com/2025/02/10/m...
Reposted by Cédric Tremblay
Review @natrevrheumatol.bsky.social
Antigen-driven T cell responses in rheumatic diseases: insights from T cell receptor repertoire studies
www.nature.com/articles/s41...
Antigen-driven T cell responses in rheumatic diseases: insights from T cell receptor repertoire studies
www.nature.com/articles/s41...
Antigen-driven T cell responses in rheumatic diseases: insights from T cell receptor repertoire studies - Nature Reviews Rheumatology
Garrido-Mesa and Brown review findings from TCR profiling studies in rheumatic diseases and discuss how improved study design might help elicit information about autoreactive T cell clones and their c...
www.nature.com
February 8, 2025 at 6:53 PM
Review @natrevrheumatol.bsky.social
Antigen-driven T cell responses in rheumatic diseases: insights from T cell receptor repertoire studies
www.nature.com/articles/s41...
Antigen-driven T cell responses in rheumatic diseases: insights from T cell receptor repertoire studies
www.nature.com/articles/s41...
Reposted by Cédric Tremblay
If you are pro-life, I recommend calling Congress to voice concern.
Yesterday’s #NIH funding cuts are likely to halt research on:
- New cancer treatments for children
- Interventions to help premature babies survive
- Supports for children with autism
- Suicide prevention
- Etc.
#MedSky #research
Yesterday’s #NIH funding cuts are likely to halt research on:
- New cancer treatments for children
- Interventions to help premature babies survive
- Supports for children with autism
- Suicide prevention
- Etc.
#MedSky #research
February 8, 2025 at 6:46 PM
Paradigm shifting!
That’s why blood cancers come back after treatment with Ruxolitinib: unphosporylated STAT5 maintains normal and premalignant blood stem cells
ashpublications.org/bloodadvance...
That’s why blood cancers come back after treatment with Ruxolitinib: unphosporylated STAT5 maintains normal and premalignant blood stem cells
ashpublications.org/bloodadvance...
Maintenance of hematopoietic stem cells by tyrosine-unphosphorylated STAT5 and JAK inhibition
Key PointsTyrosine-unphosphorylated STAT5 maintains HSCs.JAK inhibition promotes unphosphorylated STAT5 activity and maintains normal and myeloproliferativ
ashpublications.org
February 1, 2025 at 6:10 PM
Paradigm shifting!
That’s why blood cancers come back after treatment with Ruxolitinib: unphosporylated STAT5 maintains normal and premalignant blood stem cells
ashpublications.org/bloodadvance...
That’s why blood cancers come back after treatment with Ruxolitinib: unphosporylated STAT5 maintains normal and premalignant blood stem cells
ashpublications.org/bloodadvance...
What an amazing day brainstorming with colleagues & friends at the Princess Margaret Cancer Centre
January 31, 2025 at 1:03 AM
What an amazing day brainstorming with colleagues & friends at the Princess Margaret Cancer Centre
Annual ACCESS_ACCES meeting! Let’s work together for improving outcomes for children and adolescents living with cancer in Canada!
January 28, 2025 at 8:26 PM
Annual ACCESS_ACCES meeting! Let’s work together for improving outcomes for children and adolescents living with cancer in Canada!
Reposted by Cédric Tremblay
The Military Health System Research Symposium (MHSRS) is the Department of Defense's annual scientific meeting that brings together industries and researchers to advance solutions to address the unique medical needs of warfighters.
Wild
January 23, 2025 at 8:09 PM
The Military Health System Research Symposium (MHSRS) is the Department of Defense's annual scientific meeting that brings together industries and researchers to advance solutions to address the unique medical needs of warfighters.
Wild
Finally published! New #biomarker for precision #oncology in aggressive T-cell #leukemia
Thanks to CancerCare Manitoba Foundation and our patient partners for your support!
www.nature.com/articles/s41...
Thanks to CancerCare Manitoba Foundation and our patient partners for your support!
www.nature.com/articles/s41...
Targeting LMO2-induced autocrine FLT3 signaling to overcome chemoresistance in early T-cell precursor acute lymphoblastic leukemia - Leukemia
Leukemia - Targeting LMO2-induced autocrine FLT3 signaling to overcome chemoresistance in early T-cell precursor acute lymphoblastic leukemia
www.nature.com
January 23, 2025 at 3:01 PM
Finally published! New #biomarker for precision #oncology in aggressive T-cell #leukemia
Thanks to CancerCare Manitoba Foundation and our patient partners for your support!
www.nature.com/articles/s41...
Thanks to CancerCare Manitoba Foundation and our patient partners for your support!
www.nature.com/articles/s41...